Skip to main content

Aamir Malik

Equibles does not estimate personal net worth.

Get an email with a short summary when Pfizer Inc publishes a filing, an earnings call transcript or a press release.

Get PFE alerts

About Aamir Malik

Pfizer Inc reported in an 8-K filed December 12, 2023 that Aamir Malik was appointed Chief U.S. Commercial Officer, Executive Vice President, effective December 15, 2023. Aamir Malik has spoken on 1 earnings call across 1 company, most recently for Pfizer Inc on February 3, 2026. Pfizer Inc is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Pfizer Inc includes A. Bourla (CEO), I. Read (Chairman), Cecile Guegan (CFO) and 7 others.

“the Pfizer U.S. Commercial Division, which will be led by Aamir Malik, who will become Chief U.S. Commercial Officer, Executive Vice President, and continue reporting to Dr. Bourla”
Pfizer Inc Form 8-K, filed December 12, 2023 · Read the filing

Aamir Malik on recent calls

“So we think when you take that efficacy and then you combine it with a lower medication burden through a monthly dose, that's a value proposition that's going to resonate with patients, with providers and with pairs because persistency and simplicity matter.”
Other, Pfizer Inc Q4 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Pfizer Inc

Recent activity